- BNF:
- 3.1
- Status:
- Grey
- Decision Date:
- June 2015
Comments
GREY 3rd line LAMA:
- Eklira Genuair (DPI) (Decision date - August 19)
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
- 2: Lack of data on safety compared with standard therapy
search again